=== PAGE 4 ===

COMPLETE PAGE ANALYSIS:
--------------------------------------------------
Here is the exact text content from the PDF page, preserving the original layout, spacing, and structure:

Luis Caveda
Rockwell Medical, Inc
NDA 206317 MA 26; NDA 208551 MA 22

NDA numbers in all future correspondence relating to this particular matter. All
correspondence should include a subject line that clearly identifies the submission as a
Response to Untitled Letter.

The violations discussed in this letter do not necessarily constitute an exhaustive list. It is
your responsibility to ensure that your promotional materials for Triferic comply with each
applicable requirement of the FD&C Act and FDA implementing regulations.

Sincerely,

{See appended electronic signature page}

Robert Nguyen, PharmD
Regulatory Review Officer
Division of Advertising & Promotion Review 1
Office of Prescription Drug Promotion

{See appended electronic signature page}

Susannah Oâ€™Donnell, MPH, RAC
Team Leader
Division of Advertising & Promotion Review 1
Office of Prescription Drug Promotion

Page 4

Reference ID: 4521580
